Search

Your search keyword '"Lalezari, Shadan"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Lalezari, Shadan" Remove constraint Author: "Lalezari, Shadan" Publication Type Magazines Remove constraint Publication Type: Magazines
14 results on '"Lalezari, Shadan"'

Search Results

Catalog

Books, media, physical & digital resources

3. Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hocanalysis from the PROTECT VIII study

4. The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand Disease

5. Improvement in Quality of Life Outcomes and Bleeding Rates among Patients Switching from On-demand FVIII to Prophylactic BAY 94-9027 in the PROTECT VIII Study

7. Decrease in Overall and Joint Bleeding Rates with Extended-Interval Dosing: > 4 Years of Bay 94-9027 Prophylaxis in the Protect VIII Extension

9. Extended Interval Prophylaxis with Bay 94-9027 for > 4 Years Leads to Median Spontaneous Annualized Bleeding Rates < 1 in the Protect VIII Extension

10. Decrease in Overall and Joint Bleeding Rates with Extended-Interval Dosing: > 4 Years of Bay 94-9027 Prophylaxis in the Protect VIII Extension

11. Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

12. Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

13. Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Haemophilia B (PROLONG - 9FP)

14. Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Haemophilia B (PROLONG - 9FP)